
POC Testing: More FDA Approved Tests Than Ever, But Will Labs Be Reimbursed?
Revenue cycle management leaders provide their thoughts on how lab leaders may want to proceed when it comes to POC tests
Revenue cycle management leaders provide their thoughts on how lab leaders may want to proceed when it comes to POC tests
The 2025 CLFS update—what has changed, what has stayed the same, and what that means for diagnostic test reimbursement in 2025
Revenue cycle management experts weigh in on the biggest developments of 2024 and how labs can best prepare for 2025 and beyond
Though payers’ adoption of AI has made reimbursement more challenging for labs, providers can also use AI to address these issues
Two revenue cycle management experts offer tips for clinical labs to improve coverage decisions for genetic tests